Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling

Journal of Cell Biology

Volumn 209, Issue 4, 2015, Pages 579-593

  Wilmes, Stephan ^a   Beutel, Oliver ^a   Li, Zhi ^b   Francois Newton, Véronique ^b   Richter, Christian P ^a   Janning, Dennis ^a   Kroll, Cindy ^a   Hanhart, Patrizia ^a   Hötte, Katharina ^a   You, Changjiang ^a   Uzé, Gilles ^b   Pellegrini, Sandra ^b   Piehler, Jacob ^a  

^a UNIVERSITY OF OSNABRÜCK   (Germany)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; ALPHA2 INTERFERON; CELL SURFACE RECEPTOR; DEUBIQUITINASE; JANUS KINASE; ALPHA BETA INTERFERON RECEPTOR; IFNAR1 PROTEIN, HUMAN; IFNAR2 PROTEIN, HUMAN; INTERFERON; JAK1 PROTEIN, HUMAN; JANUS KINASE 1; PROTEIN BINDING; PROTEINASE; USP18 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE; COMPLEX FORMATION; DIMERIZATION; DOWN REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; LIGAND BINDING; NEGATIVE FEEDBACK; NERVE CELL; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; HELA CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN STABILITY;

ENDOPEPTIDASES; HELA CELLS; HUMANS; INTERFERON TYPE I; JANUS KINASE 1; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION;

EID: 84946720236     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201412049     Document Type: Article

References (94)

1. Abramovich, C., J. Chebath, and M. Revel. 1994. The human interferon α-receptor protein confers differential responses to human interferon-ß versus interferon-α subtypes in mouse and hamster cell transfectants. Cytokine. 6:414-424. http://dx.doi.org/10.1016/1043-4666(94)90066-3
2. Appelhans, T., C.P. Richter, V. Wilkens, S.T. Hess, J. Piehler, and K.B. Busch. 2012. Nanoscale organization of mitochondrial microcompartments revealed by combining tracking and localization microscopy. Nano Lett. 12:610-616. http://dx.doi.org/10.1021/nl203343a
3. Beutel, O., J. Nikolaus, O. Birkholz, C. You, T. Schmidt, A. Herrmann, and J. Piehler. 2014. High-fidelity protein targeting into membrane lipid microdomains in living cells. Angew. Chem. Int. Ed. Engl. 53:1311-1315. http://dx.doi.org/10.1002/anie.201306328
4. Brooks, A.J., W. Dai, M.L. O'Mara, D. Abankwa, Y. Chhabra, R.A. Pelekanos, O. Gardon, K.A. Tunny, K.M. Blucher, C.J. Morton, et al. 2014. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science. 344:1249783. http://dx.doi.org/10.1126/science.1249783
5. Brown, R.J., J.J. Adams, R.A. Pelekanos, Y. Wan, W.J. McKinstry, K. Palethorpe, R.M. Seeber, T.A. Monks, K.A. Eidne, M.W. Parker, and M.J. Waters. 2005. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat. Struct. Mol. Biol. 12:814-821. http://dx.doi.org/10.1038/nsmb977
6. Cajean-Feroldi, C., F. Nosal, P.C. Nardeux, X. Gallet, J. Guymarho, F. Baychelier, P. Sempé, M.G. Tovey, J.L. Escary, and P. Eid. 2004. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. Biochemistry. 43:12498-12512. http://dx.doi.org/10.1021/bi049111r
7. Chill, J.H., S.R. Quadt, R. Levy, G. Schreiber, and J. Anglister. 2003. The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding. Structure. 11:791-802. http://dx.doi.org/10.1016/S0969-2126(03)00120-5
8. Coelho, L.F., G. Magno de Freitas Almeida, F.J. Mennechet, A. Blangy, and G. Uzé. 2005. Interferon-α and -ß differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. Proc. Natl. Acad. Sci. USA. 102:11917-11922. http://dx.doi.org/10.1073/pnas.0502188102
9. Cohen, B., D. Novick, S. Barak, and M. Rubinstein. 1995. Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol. 15:4208-4214.
10. Constantinescu, S.N., T. Keren, M. Socolovsky, H. Nam, Y.I. Henis, and H.F. Lodish. 2001. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc. Natl. Acad. Sci. USA. 98:4379-4384. http://dx.doi.org/10.1073/pnas.081069198
11. Damjanovich, S., L. Bene, J. Matkó, A. Alileche, C.K. Goldman, S. Sharrow, and T.A. Waldmann. 1997. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study. Proc. Natl. Acad. Sci. USA. 94:13134-13139. http://dx.doi.org/10.1073/pnas.94.24.13134
12. de Bakker, B.I., A. Bodnár, E.M. van Dijk, G. Vámosi, S. Damjanovich, T.A. Waldmann, N.F. van Hulst, A. Jenei, and M.F. Garcia-Parajo. 2008. Nanometer-scale organization of the alpha subunits of the receptors for IL2 and IL15 in human T lymphoma cells. J. Cell Sci. 121:627-633. http://dx.doi.org/10.1242/jcs.019513
13. Decker, T., M. Müller, and S. Stockinger. 2005. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 5:675-687. http://dx.doi.org/10.1038/nri1684
14. Deonarain, R., D.C. Chan, L.C. Platanias, and E.N. Fish. 2002. Interferon-α/ß-receptor interactions: a complex story unfolding. Curr. Pharm. Des. 8:2131-2137. http://dx.doi.org/10.2174/1381612023393288
15. de Weerd, N.A., J.P. Vivian, T.K. Nguyen, N.E. Mangan, J.A. Gould, S.J. Braniff, L. Zaker-Tabrizi, K.Y. Fung, S.C. Forster, T. Beddoe, et al. 2013. Structural basis of a unique interferon-ß signaling axis mediated via the receptor IFNAR1. Nat. Immunol. 14:901-907. http://dx.doi.org/10.1038/ni.2667
16. Domanski, P., O.W. Nadeau, L.C. Platanias, E. Fish, M. Kellum, P. Pitha, and O.R. Colamonici. 1998. Differential use of the -ßL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFN-α2 and IFN-ß. J. Biol. Chem. 273:3144-3147. http://dx.doi.org/10.1074/jbc.273.6.3144
17. Dunne, P.D., R.A. Fernandes, J. McColl, J.W. Yoon, J.R. James, S.J. Davis, and D. Klenerman. 2009. DySCo: quantitating associations of membrane proteins using two-color single-molecule tracking. Biophys. J. 97:L5-L7. http://dx.doi.org/10.1016/j.bpj.2009.05.046
18. François-Newton, V., G. Magno de Freitas Almeida, B. Payelle-Brogard, D. Monneron, L. Pichard-Garcia, J. Piehler, S. Pellegrini, and G. Uzé. 2011. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS ONE. 6:e22200. http://dx.doi.org/10.1371/journal.pone.0022200
19. Francois-Newton, V., M. Livingstone, B. Payelle-Brogard, G. Uzé, and S. Pellegrini. 2012. USP18 establishes the transcriptional and anti-proliferative interferon α/ß differential. Biochem. J. 446:509-516. http://dx.doi.org/10.1042/BJ20120541
20. Gavutis, M., S. Lata, P. Lamken, P. Müller, and J. Piehler. 2005. Lateral ligand-receptor interactions on membranes probed by simultaneous fluorescence-interference detection. Biophys. J. 88:4289-4302. http://dx.doi.org/10.1529/biophysj.104.055855
21. Gavutis, M., E. Jaks, P. Lamken, and J. Piehler. 2006a. Determination of the two-dimensional interaction rate constants of a cytokine receptor complex. Biophys. J. 90:3345-3355. http://dx.doi.org/10.1529/biophysj.105.072546
22. Gavutis, M., S. Lata, and J. Piehler. 2006b. Probing 2-dimensional protein-protein interactions on model membranes. Nat. Protoc. 1:2091-2103. http://dx.doi.org/10.1038/nprot.2006.270
23. Hertzog, P.J., and B.R. Williams. 2013. Fine tuning type I interferon responses. Cytokine Growth Factor Rev. 24:217-225. http://dx.doi.org/10.1016/j.cytogfr.2013.04.002
24. Jaitin, D.A., L.C. Roisman, E. Jaks, M. Gavutis, J. Piehler, J. Van der Heyden, G. Uze, and G. Schreiber. 2006. Inquiring into the differential action of interferons (IFNs): an IFN-α2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-ß. Mol. Cell. Biol. 26:1888-1897. http://dx.doi.org/10.1128/MCB.26.5.1888-1897.2006
25. Jaks, E., M. Gavutis, G. Uzé, J. Martal, and J. Piehler. 2007. Differential receptor subunit affinities of type I interferons govern differential signal activation. J. Mol. Biol. 366:525-539. http://dx.doi.org/10.1016/j.jmb.2006.11.053
26. Jenei, A., J. Kormos, G. Szentesi, A.J. Veres, S. Varga, A. Bodnár, S. Damjanovich, and L. Mátyus. 2009. Non-random distribution of interleukin receptors on the cell surface. ChemPhysChem. 10:1577-1585. http://dx.doi.org/10.1002/cphc.200900242
27. Junttila, I.S., R.J. Creusot, I. Moraga, D.L. Bates, M.T. Wong, M.N. Alonso, M.M. Suhoski, P. Lupardus, M. Meier-Schellersheim, E.G. Engleman, et al. 2012. Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nat. Chem. Biol. 8:990-998. http://dx.doi.org/10.1038/nchembio.1096
28. Kalie, E., D.A. Jaitin, R. Abramovich, and G. Schreiber. 2007. An interferon α2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities. J. Biol. Chem. 282:11602-11611. http://dx.doi.org/10.1074/jbc.M610115200
29. Koyama-Honda, I., K. Ritchie, T. Fujiwara, R. Iino, H. Murakoshi, R.S. Kasai, and A. Kusumi. 2005. Fluorescence imaging for monitoring the colocalization of two single molecules in living cells. Biophys. J. 88:2126-2136. http://dx.doi.org/10.1529/biophysj.104.048967
30. Krause, C.D., E. Mei, J. Xie, Y. Jia, M.A. Bopp, R.M. Hochstrasser, and S. Pestka. 2002. Seeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cells. Mol. Cell. Proteomics. 1:805-815. http://dx.doi.org/10.1074/mcp.M200065-MCP200
31. Krause, C.D., N. Lavnikova, J. Xie, E. Mei, O.V. Mirochnitchenko, Y. Jia, R.M. Hochstrasser, and S. Pestka. 2006a. Preassembly and ligand-induced restructuring of the chains of the IFN-gamma receptor complex: the roles of Jak kinases, Stat1 and the receptor chains. Cell Res. 16:55-69. http://dx.doi.org/10.1038/sj.cr.7310008
32. Krause, C.D., E. Mei, O. Mirochnitchenko, N. Lavnikova, J. Xie, Y. Jia, R.M. Hochstrasser, and S. Pestka. 2006b. Interactions among the components of the interleukin-10 receptor complex. Biochem. Biophys. Res. Commun. 340:377-385. http://dx.doi.org/10.1016/j.bbrc.2005.11.182
33. Krause, C.D., G. Digioia, L.S. Izotova, J. Xie, Y. Kim, B.J. Schwartz, O.V. Mirochnitchenko, and S. Pestka. 2013. Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity. Cytokine. 64:286-297. http://dx.doi.org/10.1016/j.cyto.2013.06.309
34. Kusumi, A., T.K. Fujiwara, R. Chadda, M. Xie, T.A. Tsunoyama, Z. Kalay, R.S. Kasai, and K.G. Suzuki. 2012. Dynamic organizing principles of the plasma membrane that regulate signal transduction: commemorating the fortieth anniversary of Singer and Nicolson's fluid-mosaic model. Annu. Rev. Cell Dev. Biol. 28:215-250. http://dx.doi.org/10.1146/annurevcellbio-100809-151736
35. Lamken, P., S. Lata, M. Gavutis, and J. Piehler. 2004. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. J. Mol. Biol. 341:303-318. http://dx.doi.org/10.1016/j.jmb.2004.05.059
36. Lamken, P., M. Gavutis, I. Peters, J. Van der Heyden, G. Uzé, and J. Piehler. 2005. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1. J. Mol. Biol. 350:476-488. http://dx.doi.org/10.1016/j.jmb.2005.05.008
37. LaPorte, S.L., Z.S. Juo, J. Vaclavikova, L.A. Colf, X. Qi, N.M. Heller, A.D. Keegan, and K.C. Garcia. 2008. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 132:259-272. http://dx.doi.org/10.1016/j.cell.2007.12.030
38. Lavoie, T.B., E. Kalie, S. Crisafulli-Cabatu, R. Abramovich, G. DiGioia, K. Moolchan, S. Pestka, and G. Schreiber. 2011. Binding and activity of all human alpha interferon subtypes. Cytokine. 56:282-289. http://dx.doi.org/10.1016/j.cyto.2011.07.019
39. Levin, D., D. Harari, and G. Schreiber. 2011. Stochastic receptor expression determines cell fate upon interferon treatment. Mol. Cell. Biol. 31:3252-3266. http://dx.doi.org/10.1128/MCB.05251-11
40. Levin, D., W.M. Schneider, H.H. Hoffmann, G. Yarden, A.G. Busetto, O. Manor, N. Sharma, C.M. Rice, and G. Schreiber. 2014. Multifaceted activities of type I interferon are revealed by a receptor antagonist. Sci. Signal. 7:ra50. http://dx.doi.org/10.1126/scisignal.2004998
41. Li, Z., J.J. Strunk, P. Lamken, J. Piehler, and T. Walz. 2008. The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling. J. Mol. Biol. 377:715-724. http://dx.doi.org/10.1016/j.jmb.2007.12.005
42. Löchte, S., S. Waichman, O. Beutel, C. You, and J. Piehler. 2014. Live cell micropatterning reveals the dynamics of signaling complexes at the plasma membrane. J. Cell Biol. 207:407-418. http://dx.doi.org/10.1083/jcb.201406032
43. Low-Nam, S.T., K.A. Lidke, P.J. Cutler, R.C. Roovers, P.M. van Bergen en Henegouwen, B.S. Wilson, and D.S. Lidke. 2011. ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand binding. Nat. Struct. Mol. Biol. 18:1244-1249. http://dx.doi.org/10.1038/nsmb.2135
44. Malakhova, O.A., K.I. Kim, J.K. Luo, W. Zou, K.G. Kumar, S.Y. Fuchs, K. Shuai, and D.E. Zhang. 2006. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25:2358-2367. http://dx.doi.org/10.1038/sj.emboj.7601149
45. Marchetti, M., M.N. Monier, A. Fradagrada, K. Mitchell, F. Baychelier, P. Eid, L. Johannes, and C. Lamaze. 2006. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol. Biol. Cell. 17:2896-2909. http://dx.doi.org/10.1091/mbc.E06-01-0076
46. Moraga, I., D. Harari, G. Schreiber, G. Uzé, and S. Pellegrini. 2009. Receptor density is key to the α2/ß interferon differential activities. Mol. Cell. Biol. 29:4778-4787. http://dx.doi.org/10.1128/MCB.01808-08
47. Moraga, I., J. Spangler, J.L. Mendoza, and K.C. Garcia. 2014. Multifarious determinants of cytokine receptor signaling specificity. Adv. Immunol. 121:1-39. http://dx.doi.org/10.1016/B978-0-12-800100-4.00001-5
48. Muster, B., W. Kohl, I. Wittig, V. Strecker, F. Joos, W. Haase, J. Bereiter-Hahn, and K. Busch. 2010. Respiratory chain complexes in dynamic mitochondria display a patchy distribution in life cells. PLoS ONE. 5:e11910. http://dx.doi.org/10.1371/journal.pone.0011910
49. Novick, D., B. Cohen, and M. Rubinstein. 1994. The human interferon α2/ß receptor: characterization and molecular cloning. Cell. 77:391-400. http://dx.doi.org/10.1016/0092-8674(94)90154-6
50. Pan, M., E. Kalie, B.J. Scaglione, E.S. Raveche, G. Schreiber, and J.A. Langer. 2008. Mutation of the IFNAR-1 receptor binding site of human IFN-α2 generates type I IFN competitive antagonists. Biochemistry. 47:12018-12027. http://dx.doi.org/10.1021/bi801588g
51. Parmar, S., and L.C. Platanias. 2003. Interferons: mechanisms of action and clinical applications. Curr. Opin. Oncol. 15:431-439. http://dx.doi.org/10.1097/00001622-200311000-00005
52. Pestka, S., C.D. Krause, and M.R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202:8-32. http://dx.doi.org/10.1111/j.0105-2896.2004.00204.x
53. Piehler, J., and G. Schreiber. 1999a. Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNα2. J. Mol. Biol. 289:57-67. http://dx.doi.org/10.1006/jmbi.1999.2726
54. Piehler, J., and G. Schreiber. 1999b. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2. J. Mol. Biol. 294:223-237. http://dx.doi.org/10.1006/jmbi.1999.3230
55. Piehler, J., L.C. Roisman, and G. Schreiber. 2000. New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J. Biol. Chem. 275:40425-40433. http://dx.doi.org/10.1074/jbc.M006854200
56. Piehler, J., C. Thomas, K.C. Garcia, and G. Schreiber. 2012. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol. Rev. 250:317-334. http://dx.doi.org/10.1111/imr.12001
57. Quadt-Akabayov, S.R., J.H. Chill, R. Levy, N. Kessler, and J. Anglister. 2006. Determination of the human type I interferon receptor binding site on human interferon-α2 by cross saturation and an NMR-based model of the complex. Protein Sci. 15:2656-2668. http://dx.doi.org/10.1110/ps.062283006
58. Rani, M.R., G.R. Foster, S. Leung, D. Leaman, G.R. Stark, and R.M. Ransohoff. 1996. Characterization of ß-R1, a gene that is selectively induced by interferon ß (IFN-ß) compared with IFN-α. J. Biol. Chem. 271:22878-22884. http://dx.doi.org/10.1074/jbc.271.37.22878
59. Remy, I., I.A. Wilson, and S.W. Michnick. 1999. Erythropoietin receptor activation by a ligand-induced conformation change. Science. 283:990-993. http://dx.doi.org/10.1126/science.283.5404.990
60. Ring, A.M., J.X. Lin, D. Feng, S. Mitra, M. Rickert, G.R. Bowman, V.S. Pande, P. Li, I. Moraga, R. Spolski, et al. 2012. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat. Immunol. 13:1187-1195. http://dx.doi.org/10.1038/ni.2449
61. Roder, F., S. Wilmes, C.P. Richter, and J. Piehler. 2014. Rapid transfer of transmembrane proteins for single molecule dimerization assays in polymersupported membranes. ACS Chem. Biol. 9:2479-2484. http://dx.doi.org/10.1021/cb5005806
62. Roisman, L.C., J. Piehler, J.Y. Trosset, H.A. Scheraga, and G. Schreiber. 2001. Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking. Proc. Natl. Acad. Sci. USA. 98:13231-13236. http://dx.doi.org/10.1073/pnas.221290398
63. Roisman, L.C., D.A. Jaitin, D.P. Baker, and G. Schreiber. 2005. Mutational analysis of the IFNAR1 binding site on IFNα2 reveals the architecture of a weak ligand-receptor binding-site. J. Mol. Biol. 353:271-281. http://dx.doi.org/10.1016/j.jmb.2005.08.042
64. Runkel, L., C. deDios, M. Karpusas, M. Betzenhauser, C. Muldowney, M. Zafari, C.D. Benjamin, S. Miller, P.S. Hochman, and A. Whitty. 2000. Systematic mutational mapping of sites on human interferon-ß-1a that are important for receptor binding and functional activity. Biochemistry. 39:2538-2551. http://dx.doi.org/10.1021/bi991631c
65. Ruprecht, V., M. Brameshuber, and G.J. Schutz. 2010a. Two-color single molecule tracking combined with photobleaching for the detection of rare molecular interactions in fluid biomembranes. Soft Matter. 6:568-581. http://dx.doi.org/10.1039/B916734J
66. Ruprecht, V., J. Weghuber, S. Wieser, and G.J. Schütz. 2010b. Measuring colocalization by dual color single molecule imaging: Thresholds, error rates, and sensitivity. Advances in Planar Lipid Bilayers and Liposomes. 12:21-40. http://dx.doi.org/10.1016/B978-0-12-381266-7.00002-X
67. Russell-Harde, D., T.C. Wagner, H.D. Perez, and E. Croze. 1999. Formation of a uniquely stable type I interferon receptor complex by interferon ß is dependent upon particular interactions between interferon ß and its receptor and independent of tyrosine phosphorylation. Biochem. Biophys. Res. Commun. 255:539-544. http://dx.doi.org/10.1006/bbrc.1998.0105
68. Sander, J., M. Ester, H.P. Kriegel, and X.W. Xu. 1998. Density-based clustering in spatial databases: The algorithm GDBSCAN and its applications. Data Min. Knowl. Discov. 2:169-194. http://dx.doi.org/10.1023/A:1009745219419
69. Schneider, W.M., M.D. Chevillotte, and C.M. Rice. 2014. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32:513-545. http://dx.doi.org/10.1146/annurev-immunol-032713-120231
70. Schreiber, G., and M.R. Walter. 2010. Cytokine-receptor interactions as drug targets. Curr. Opin. Chem. Biol. 14:511-519. http://dx.doi.org/10.1016/j.cbpa.2010.06.165
71. Schütz, G.J., W. Trabesinger, and T. Schmidt. 1998. Direct observation of ligand colocalization on individual receptor molecules. Biophys. J. 74:2223-2226. http://dx.doi.org/10.1016/S0006-3495(98)77931-7
72. Semrau, S., L. Holtzer, M. González-Gaitán, and T. Schmidt. 2011. Quantification of biological interactions with particle image cross-correlation spectros-copy (PICCS). Biophys. J. 100:1810-1818. http://dx.doi.org/10.1016/j.bpj.2010.12.3746
73. Sergé, A., N. Bertaux, H. Rigneault, and D. Marguet. 2008. Dynamic multipletarget tracing to probe spatiotemporal cartography of cell membranes. Nat. Methods. 5:687-694. http://dx.doi.org/10.1038/nmeth.1233
74. Shimozono, S., and A. Miyawaki. 2008. Engineering FRET constructs using CFP and YFP. Methods Cell Biol. 85:381-393. http://dx.doi.org/10.1016/S0091-679X(08)85016-9
75. Strunk, J.J., I. Gregor, Y. Becker, Z. Li, M. Gavutis, E. Jaks, P. Lamken, T. Walz, J. Enderlein, and J. Piehler. 2008. Ligand binding induces a conformational change in ifnar1 that is propagated to its membrane-proximal domain. J. Mol. Biol. 377:725-739. http://dx.doi.org/10.1016/j.jmb.2008.01.017
76. Subramaniam, P.S., S.A. Khan, C.H. Pontzer, and H.M. Johnson. 1995. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Proc. Natl. Acad. Sci. USA. 92:12270-12274. http://dx.doi.org/10.1073/pnas.92.26.12270
77. 2+ signaling: single-molecule tracking study 2. J. Cell Biol. 177:731-742. http://dx.doi.org/10.1083/jcb.200609175
78. Suzuki, K.G., R.S. Kasai, K.M. Hirosawa, Y.L. Nemoto, M. Ishibashi, Y. Miwa, T.K. Fujiwara, and A. Kusumi. 2012. Transient GPI-anchored protein homodimers are units for raft organization and function. Nat. Chem. Biol. 8:774-783. http://dx.doi.org/10.1038/nchembio.1028
79. Tenhumberg, S., B. Schuster, L. Zhu, M. Kovaleva, J. Scheller, K.J. Kallen, and S. Rose-John. 2006. gp130 dimerization in the absence of ligand: preformed cytokine receptor complexes. Biochem. Biophys. Res. Commun. 346:649-657. http://dx.doi.org/10.1016/j.bbrc.2006.05.173
80. Thomas, C., I. Moraga, D. Levin, P.O. Krutzik, Y. Podoplelova, A. Trejo, C. Lee, G. Yarden, S.E. Vleck, J.S. Glenn, et al. 2011. Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell. 146:621-632. http://dx.doi.org/10.1016/j.cell.2011.06.048
81. Uzé, G., G. Lutfalla, M.T. Bandu, D. Proudhon, and K.E. Mogensen. 1992. Behavior of a cloned murine interferon α/ß receptor expressed in homospecific or heterospecific background. Proc. Natl. Acad. Sci. USA. 89:4774-4778. http://dx.doi.org/10.1073/pnas.89.10.4774
82. Uzé, G., G. Schreiber, J. Piehler, and S. Pellegrini. 2007. The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 316:71-95.
83. Vámosi, G., A. Bodnár, G. Vereb, A. Jenei, C.K. Goldman, J. Langowski, K. Tóth, L. Mátyus, J. Szöllösi, T.A. Waldmann, and S. Damjanovich. 2004. IL-2 and IL-15 receptor α-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc. Natl. Acad. Sci. USA. 101:11082-11087. http://dx.doi.org/10.1073/pnas.0403916101
84. VandeVondele, S., J. Voros, and J.A. Hubbell. 2003. RGD-grafted poly-Llysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol. Bioeng. 82:784-790. http://dx.doi.org/10.1002/bit.10625
85. Vogelsang, J., R. Kasper, C. Steinhauer, B. Person, M. Heilemann, M. Sauer, and P. Tinnefeld. 2008. A reducing and oxidizing system minimizes photobleaching and blinking of fluorescent dyes. Angew. Chem. Int. Ed. Engl. 47:5465-5469. http://dx.doi.org/10.1002/anie.200801518
86. Waichman, S., M. Bhagawati, Y. Podoplelova, A. Reichel, A. Brunk, D. Paterok, and J. Piehler. 2010. Functional immobilization and patterning of proteins by an enzymatic transfer reaction. Anal. Chem. 82:1478-1485. http://dx.doi.org/10.1021/ac902608a
87. Waichman, S., F. Roder, C.P. Richter, O. Birkholz, and J. Piehler. 2013. Diffusion and interaction dynamics of individual membrane protein complexes confined in micropatterned polymer-supported membranes. Small. 9:570-577. http://dx.doi.org/10.1002/smll.201201530
88. Whitty, A., N. Raskin, D.L. Olson, C.W. Borysenko, C.M. Ambrose, C.D. Benjamin, and L.C. Burkly. 1998. Interaction affinity between cytokine receptor components on the cell surface. Proc. Natl. Acad. Sci. USA. 95:13165-13170. http://dx.doi.org/10.1073/pnas.95.22.13165
89. Yang, N., X. Wang, J. Jiang, and S.J. Frank. 2007. Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation. Mol. Endocrinol. 21:1642-1655. http://dx.doi.org/10.1210/me.2006-0458
90. Yin, J., P.D. Straight, S.M. McLoughlin, Z. Zhou, A.J. Lin, D.E. Golan, N.L. Kelleher, R. Kolter, and C.T. Walsh. 2005. Genetically encoded short peptide tag for versatile protein labeling by Sfp phosphopantetheinyl transferase. Proc. Natl. Acad. Sci. USA. 102:15815-15820. http://dx.doi.org/10.1073/pnas.0507705102
91. Yoon, S.I., B.C. Jones, N.J. Logsdon, and M.R. Walter. 2005. Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain. Structure. 13:551-564. http://dx.doi.org/10.1016/j.str.2005.01.016
92. Yoon, S.I., B.C. Jones, N.J. Logsdon, B.D. Harris, S. Kuruganti, and M.R. Walter. 2012. Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties. J. Biol. Chem. 287:26586-26595. http://dx.doi.org/10.1074/jbc.M112.376707
93. Zaks-Zilberman, M., A.E. Harrington, T. Ishino, and I.M. Chaiken. 2008. Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging. J. Biol. Chem. 283:13398-13406. http://dx.doi.org/10.1074/jbc.M710230200
94. Zhang, X., J. Gureasko, K. Shen, P.A. Cole, and J. Kuriyan. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell. 125:1137-1149. http://dx.doi.org/10.1016/j.cell.2006.05.013